Russia to invest in manufacturing therapeutic biopharmaceuticals for MND

A project for the production of vaccines and biopharmaceuticals has been approved by the Supervisory Council of RUSNANO, which will be executed in conjunction with NTpharma. Project plans include the development of two vaccines and three biopharmaceuticals for the treatment of cancer-related toxicity and motor neuron disease. The project launch is scheduled for the first quarter of 2010 with target capacity being reached in the third quarter of 2012.

Click here to read more.

Share this: